| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
27 |
| issn |
2040-6207
2040-6215 |
| issueIdentifier |
1 |
| pageRange |
17-27 |
| publicationName |
Therapeutic Advances in Hematology |
| startingPage |
17 |
| bibliographicCitation |
Padron E, Fernandez H. Anthracycline dose intensification in young adults with acute myeloid leukemia. Therapeutic Advances in Hematology. 2011 Nov 02;3(1):17–27. doi: 10.1177/2040620711427069. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cee81b8faf5d2b25571e956643b512ee
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5c2c86ed01e933fddec7d3760c4df8bb |
| date |
2011-11-02^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://doi.org/10.1177/2040620711427069
https://pubmed.ncbi.nlm.nih.gov/23556109
https://pubmed.ncbi.nlm.nih.gov/PMC3573430 |
| isPartOf |
https://portal.issn.org/resource/ISSN/2040-6215
https://portal.issn.org/resource/ISSN/2040-6207
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/39565 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Anthracycline dose intensification in young adults with acute myeloid leukemia |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9731
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6253
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30323 |